16th and 17th April 2020

The CMC presents the first Scientific, Clinical and Regulatory Cannabinoid Conference in collaboration with the National Institute for Health Research (NIHR).

The aims of the conference are:

  • Assemble leading preclinical scientists, clinical researchers, national regulators (MHRA andNICE), government bodies and cannabis-based medicinal products (CBMP) pharmaceuticalsuppliers together to align research strategies.

  • Grow and stimulate CBMP pharmaceutical industry in the UK.

  • Identify the implementation challenges for CBMPs clinical research.
  • Educate healthcare professions.